A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis. Plavina T, Fox EJ, Lucas N, Muralidharan K K, Mikol D J Clin Pharmacol. 2016 Feb 2. PMID: 26835603. Abstract CommentRecommendBookmarkWatch